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Abstract
Background: Chronic fatigue syndrome (CFS) is a debilitating illness with no known cause or
effective therapy. Population-based epidemiologic data on CFS prevalence are critical to put CFS in
a realistic context for public health officials and others responsible for allocating resources.
Methods: Based on a random-digit dialing survey we ascertained CFS cases and controls to
estimate the prevalence of CFS in metropolitan, urban, and rural populations of Georgia. This
report focuses on the 5,623 of 19,381 respondents ages 18 to 59 years old. Fatigued (2,438),
randomly selected unwell not fatigued (1,429) and randomly selected well (1,756) respondents
completed telephone questionnaires concerning fatigue, other symptoms, and medical history.
Subsets of those identified by interview as having CFS-like illness (292), chronic unwellness which
was not CFS-like (268 – randomly selected), and well subjects (223, matched to those with CFS-
like illness on sex, race, and age) completed a clinical evaluation.
Results: We estimated that 2.54% of persons 18 to 59 years of age suffered from CFS. There were
no significant differences in prevalence of CFS between metropolitan, urban or rural populations
or between white and black residents of the three regions. However, there were significant
differences in female-to-male ratios of prevalence across the strata (metropolitan female: male 11.2
: 1, urban 1.7 : 1, rural 0.8 : 1).
Conclusion: We estimated that 2.54% of the Georgia population suffers from CFS, which is 6- to
10-fold higher than previous population-based estimates in other geographic areas. These
differences may reflect broader screening criteria and differences in the application of the case
definition. However, we cannot exclude the possibility that CFS prevalence may be higher in
Georgia than other areas where it has been measured. Although the study did not identify
differences in overall prevalence between metropolitan, urban, and rural Georgia populations, it
did suggest the need for additional stratified analyses by geographic strata.
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Background
Chronic fatigue syndrome (CFS) is a complex medical and
public health problem that is associated with severe per-
sonal suffering and loss. The median duration of illness is
7 years, a quarter of those with the illness are unemployed
or receiving disability, and the average affected family for-
goes approximately $20,000 in annual earnings and
wages [1]. Yet, fewer than 20 percent have received medi-
cal care for CFS [2,3]. Despite more than 3,000 articles in
the peer-reviewed medical literature, the pathophysiology
of CFS is not well understood. There are no diagnostic lab-
oratory abnormalities or clinical tests. There is no public
health control or prevention strategy for CFS.
An understanding of the prevalence and distribution of
CFS in the general population is fundamental to focusing
etiologic research, estimating the effects of CFS on quality
of life and productivity, and devising control and preven-
tion strategies. The few studies which have estimated the
prevalence of CFS in defined populations [4,5,3,6]
reported prevalence estimates for CFS in adults to be
between 0.24% [3] and 0.42% [5], and prevalence for
CFS-like illness between 0.25% [4] and 1.67% [6]. These
studies used different sampling, screening, and evaluation
strategies; so, their results are not strictly comparable.
They also identified relatively small numbers of persons
with CFS, and thus they lack statistical power. However,
all four studies documented that CFS disproportionately
affects women, is more common in the economically dis-
advantaged, and affects racial/ethnic minorities at rates
equal to or greater than those of whites.
We conducted the survey herein reported to estimate the
prevalence of CFS in racial/ethnic groups representative of
defined metropolitan, urban, and rural populations. The
primary objective was to obtain information that could be
used as a basis for the development and evaluation of a
control strategy for CFS. The study also rectified two major
weaknesses of previous studies. First, previous studies
have screened the population for individuals with fatigue
and then evaluated them for CFS. Although fatigue is cen-
tral to CFS, focusing on fatigue ignores other important
dimensions of the illness such as impaired memory or
concentration, unrefreshing sleep, and bodily pain. For
many persons who suffer from CFS, these symptoms,
rather than fatigue, constitute the primary complaint. In
addition, a household informant may not be familiar
with specific symptoms but can identify whether some-
one is generally unwell or not. Thus, rather than limiting
the initial screening stage to fatigued and non-fatigued
persons, this survey cast a broader screening net, utilizing
household informants to identify unwell (fatigue, prob-
lems with memory/concentration, unrefreshing sleep, or
pain) members of these populations. We then conducted
detailed evaluations of participants who were identified
by a household informant as unwell to further identify
those with CFS. Second, previous studies have not defined
CFS in a rigorous reproducible manner (i.e., they did not
use validated and standardized instruments to measure
fatigue, impairment, and accompanying symptoms) [7].
To address this deficit, we used validated and standard-
ized instruments to define CFS according to criteria of the
1994 case definition [8].
Methods
The CDC Institutional Review Board, as required by
Department of Health and Human Services regulations,
approved the study. All participants were volunteers who
gave informed consent. The study was conducted in Eng-
lish. Non-English speaking respondents were not
included.
Study Design
Metropolitan, urban, rural
The definitions of metropolitan, urban and rural geo-
graphic strata are complex. The U.S. Office of Manage-
ment and Budget defines several categories of
metropolitan statistical areas according to specific stand-
ards. In general, metropolitan areas contain at least a mil-
lion residents living in a core area (i.e., central city),
together with adjacent communities that have a high
degree of economic and social integration with that core.
Atlanta, with approximately 4 million residents, is a met-
ropolitan city. The Census Bureau defines urban and rural
areas independently of OMB's classification. Urban and
rural can occur inside of and outside of metropolitan
areas. Typically, settled areas of 2,500 or more are consid-
ered to be urban and the remainder rural. Based on these
definitions, we determined that the cities of Macon and
Warner Robins (with populations of 300,000 and 48,000,
respectively) were urban. For this study, we considered the
counties surrounding Macon and Warner Robins to be
rural.
Survey in general
The survey was conducted between September 2004 and
July 2005. It included residents of three areas of Georgia:
metropolitan (Atlanta – Fulton and DeKalb counties),
urban (Macon – Bibb County and Warner Robins in adja-
cent Houston County), and rural (10 counties surround-
ing Bibb County – Houston -excluding Warner Robins,
Baldwin, Bleckley, Crawford, Jones, Macon, Monroe,
Peach, Twiggs, and Wilkinson). The survey used the same
strategy as previously reported CDC population surveys of
CFS [7,6]. We used list-assisted random-digit dialing [9]
and an advance letter [10] to contact households contain-
ing persons aged 18–59 years in the three population
strata.Population Health Metrics 2007, 5:5 http://www.pophealthmetrics.com/content/5/1/5
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Telephone screening interviews
In contrast to our previous studies, which screened house-
holds for fatigue, in this study we modified the initial
screening interview to cover a broader range of CFS defin-
ing symptoms. In brief, the screening interview asked a
household informant (=> 18 years) to report the age, sex,
ethnicity and health status of each household member
aged 18 and older and to identify unwell household mem-
bers, who the informant noticed to have at least one of the
CFS defining symptoms (fatigue, cognitive impairment,
unrefreshing sleep, muscle pain, joint pain, sore throat,
tender lymph nodes, or headache) for ≥ 1 month, and well
residents, who had none of these problems for => 1
month.
Detailed telephone interviews
Household residents between 18 and 59 years of age who
were identified by the informant as unwell with fatigue,
randomly selected persons identified as unwell without
fatigue (i.e., identified with cognitive impairment, unre-
freshing sleep, muscle pain, joint pain, sore throat, tender
lymph nodes, or headache), and a random sample of peo-
ple identified as well were asked to complete a detailed
telephone interview. The detailed interview covered
fatigue status and duration, other symptoms, race ("What
race do you consider yourself to be? Please note that you
may choose more than one option. White, black of Afri-
can American, Asian, American Indian or Alaskan Native,
native Hawaiian or other Pacific islander"), self-identified
Hispanic/Latino or Spanish origin or descent, other
demographic characteristics, and medical history. Based
on their responses to the detailed interview, respondents
were classified as: 1) having a medical or psychiatric con-
dition considered exclusionary for CFS [7]; 2) having CFS-
like illness if they reported severe fatigue lasting 6 months
or longer that was not alleviated by rest, that caused sub-
stantial reduction in occupational, educational, social or
personal activities, and that was accompanied by at least
4 of the CFS case defining symptoms [11]; 3) being chron-
ically unwell (reporting any of the CFS defining symp-
toms) with or without fatigue);, 4) or being well.
Clinical evaluation
All respondents between 18 and 59 years who had no
exclusionary conditions per interview, and were classified
as having a CFS-like illness were invited for a one-day clin-
ical examination to further investigate exclusionary medi-
cal and psychiatric conditions. We also invited a similar
number of randomly selected participants identified with
chronic unwellness (at least six months of unwellness with
or without fatigue but not CFS-like). Finally, we invited
well participants, matched to the CFS-like on geographic
stratum, sex, race/ethnicity and age (within 3 years), for a
one-day clinical examination. Those from the urban or
rural areas attended a clinic in Macon, and those from
Atlanta attended a similar clinic in Atlanta. No more than
4 participants attended a clinic on any day, and appoint-
ments were staggered for optimal flow. Clinic staff with
responsibilities for examinations was not aware of partic-
ipants' telephone interview responses or classification.
The authors and CDC CFS Research Program staff
attended clinics on a regular basis to assess operations.
Case definitions
Telephone interview
Study participants who underwent a detailed telephone
interview and met criteria of the 1994 CFS case definition
[11] were classified as CFS-like. In brief, criteria for classi-
fication as CFS-like on telephone included persistent or
relapsing fatigue of at least 6 months' duration; the fatigue
was not relieved by rest and caused substantial reduction
in previous levels of occupational, educational, social, or
personal activities. Exclusionary conditions included self-
reported medical or psychiatric conditions that could
cause the fatigue. Finally, the medically/psychiatrically
unexplained fatigue must have been accompanied by at
least 4 of the 8 CFS case defining symptoms [11]: 1) unu-
sual post-exertional malaise; 2) unrefreshing sleep; 3)
impaired memory or concentration; 4) headaches; 5)
muscle pain; 6) multi-joint paint without swelling or red-
ness; 7) sore throat; 8) tender cervical/axillary lymph
nodes. CFS-like subjects differ from CFS by not having
been evaluated clinically in the study.
Clinic
The objective of the clinical evaluation was to classify par-
ticipants' clinical status and diagnose exclusionary medi-
cal and psychiatric conditions. As recommended by the
International CFS Study Group [7], participants were clas-
sified as CFS, unexplained chronic illness not meeting cri-
teria for CFS (termed ISF), or well by using standardized
reproducible criteria for measuring specifics of the 1994
case definition [8]. We used the Multidimensional Fatigue
Inventory (MFI) [12] to assess fatigue status. For classifica-
tion as CFS, those with a score => well-population medi-
ans on the general fatigue or reduced activity scales of the
MFI were considered to meet fatigue criteria of the 1994
case definition. Functional impairment was assessed by
the medical outcomes survey short form-36 (SF-36) [13].
For classification as CFS, those with a score =< 25th per-
centile of population norms in the physical function or
role physical, or social function, or role emotional sub-
scales of the SF-36 were considered to have substantial
reduction in activities as specified in the 1994 definition.
Finally we used the CDC Symptom Inventory (SI) [14] to
evaluate occurrence, frequency and severity of the 8 CFS-
defining accompanying symptoms. The SF-36, MFI and SI
domain scores require complete data for the subscales. We
imputed a zero value in the case of one-item non-response
for subscales contributing to the relevant domains. ForPopulation Health Metrics 2007, 5:5 http://www.pophealthmetrics.com/content/5/1/5
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classification as CFS, those reporting => 4 case defining
symptoms and who scored > 25 on the SI concerning fre-
quency and severity of the 8 case defining symptoms [14]
were considered to meet accompanying symptom criteria
of the 1994 case definition. Participants who fulfilled
some, but not all of these criteria were classified as ISF.
Those who met none of the criteria were considered to be
well. The MFI, SF-36 and SI are self-administered paper
and pencil forms. A trained clinic supervisor reviewed
forms and helped subjects complete missing or misunder-
stood portions.
To screen for medical conditions considered exclusionary
for CFS [11,7], participants completed past medical his-
tory questionnaires and were requested to bring all their
medications and supplements to the clinic. A licensed
nurse practitioner or physician assistant reviewed subjects'
past medical histories and medications to clarify omis-
sions or discrepancies and also catalogued all medica-
tions. Relevant information was brought to the attention
of the study physicians. A specifically trained licensed
physician then performed a standardized physical exami-
nation [3]. The examination was expanded if there were
any concerns. The examiner recorded a differential diag-
nosis. Blood and urine specimens were obtained for labo-
ratory screening tests to identify possible underlying or
contributing medical conditions as stipulated by the case
definition [11,7]. Laboratory tests included a complete
blood count with differential, c-reactive protein, alanine
aminotransferase (ALT), SGPT, albumin, alkaline phos-
phatase, asparatate aminotransferase (AST), SGOT, total
bilirubin, calcium, carbon dioxide, chloride, creatinine,
glucose, potassium, total protein, sodium, urea nitrogen
BUN, antinuclear antibodies, rheumatoid factor, TSH,
free T4, and urinalysis.
To screen for psychiatric conditions considered exclusion-
ary for CFS [11,7], a trained and experienced licensed psy-
chiatric social worker, clinical psychologist, psychiatric
nurse practitioner or certified psychiatric research nurse
administered the research version of the SCID [15]. They
underwent specific training for the SCID. Psychologists on
the CDC CFS Research Program monitored their tech-
nique on a regular basis. The SCID included the screening
module, mood episodes, psychotic symptoms, psychotic
disorders, mood disorders, substance use disorders, anxi-
ety disorders, somatoform disorders, eating disorders, and
adjustment disorders.
A review committee of CDC and Emory University physi-
cians and psychologists reviewed medical and psychiatric
evaluations to determine the presence of medical and psy-
chiatric conditions exclusionary for CFS. Members of the
review committee were not aware of subjects' classifica-
tion either on phone interview or in the clinic.
Weighting
Prevalence estimates and statistical analyses utilized
weighted data. The survey weights maintained (through
the stages of the survey) the relation between the sample
and the population in each geographic stratum, and they
included several adjustments that are customarily
employed to reduce bias. In the process of developing
weights, one step adjusted for households that did not
have telephones. To estimate the proportion of house-
holds that did not have a telephone in each of the three
geographic strata, we analyzed data from the 5% public-
use microdata samples (PUMS) of the 2000 Census. For
the metropolitan stratum, the analysis used PUMS data
from De Kalb and Fulton Counties. The other two strata,
however, do not correspond exactly to geographic entities
for which data are available in the PUMS. Thus, the anal-
ysis for the urban stratum used data from Bibb County;
the rural stratum used data from a larger combination of
counties that contained the counties of that stratum. The
resulting estimates of the proportion of households that
did not have a telephone were 1.68% in the metropolitan
stratum, 3.66% in the urban stratum, and 6.35% in the
rural stratum.
Adjustments for nonresponse on the detailed telephone
interview and nonresponse on the clinical evaluation kept
the categories of illness separate; thus, to the extent possi-
ble, respondents accounted for nonrespondents who
belonged to the same illness category (and shared other
key characteristics). The adjustment factor, applied to the
weight of each respondent, equaled the ratio of the sum of
the weights (at that stage) of respondents and nonre-
spondents to the sum of the weights of respondents.
Another adjustment, at the household level, used data on
interruptions in telephone service to compensate for the
inability of the telephone survey to reach households that
did not have telephone service.
Households completing the screening interview received a
base sampling weight (64.4 in the metropolitan stratum,
6.4 in the urban stratum, and 4.9 in the rural Stratum)
equal to the reciprocal of the probability that the house-
hold's telephone number was selected for the sample.
Base weights were reduced for multiple residential tele-
phone numbers in the household (either by a factor of 2
or a factor of 3) and adjusted for households that did not
complete screening interviews (by a factor of 1.03 in each
stratum), for numbers associated with undetermined res-
idential status (by a factor of 2.4, 2.3, and 2.1, respec-
tively), and for non-telephone households in the
population (by a factor of 1.7, 2.2, and 2.3 for households
that reported interruptions in telephone service and by a
factor of 1.24, 1.38, and 1.04 for households that did not
report interruptions) [16,17]. (The household weights
ranged from 66 to 268 in the metropolitan stratum, fromPopulation Health Metrics 2007, 5:5 http://www.pophealthmetrics.com/content/5/1/5
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7 to 34 in the urban stratum, and from 4 to 24 in the rural
stratum.)
Subjects selected for detailed interviews received an initial
interview weight equal to their household weight multi-
plied by the reciprocal of their probability of selection
(the probability of selecting a household as a source of a
subject ranged from 0.32 to 1.0 for unwell subjects and
from 0.17 to 1.0 for well subjects; the probability of select-
ing an individual subject within the household was the
reciprocal of the number of unwell, respectively well, per-
sons in the household; subjects with prolonged fatigue
were selected with certainty). Within each combination of
stratum (metropolitan, urban, rural) and illness classifica-
tion (fatigued, unwell, well), initial weights were adjusted
for nonresponse on the detailed interview, within a total
of 195 cells defined by sex, age, and race (the adjustment
factors ranged from 1.05 to 2.25 and exceeded 2.0 in only
22 cells). A further adjustment in each stratum used an
iterative form of post-stratification to bring the weighted
totals into agreement with control totals from the 2000
Census on race and on the combination of sex and age.
This process produced an interview weight for each sub-
ject who completed a detailed interview. (The interview
weights ranged from 84 to 16,723 in the metropolitan
stratum, from 5 to 822 in the urban stratum, and from 4
to 892 in the rural stratum.)
Each CFS-like subject who completed a clinical evaluation
received a clinical-evaluation weight, which incorporated
an adjustment for nonresponse on the clinical evaluation
within stratum-specific cells defined by sex and age (over
the 19 cells the adjustment factor ranged from 1.11 to
2.71). For chronically unwell subjects the clinical-evalua-
tion weights incorporated a parallel adjustment for non-
response (over the 14 cells the adjustment factor ranged
from 1.52 to 2.61), preceded by an adjustment for selec-
tion of the subsample (by a factor of 3.02, 3.88, and 2.89
in the respective strata). (The clinical-evaluation weights
ranged from 193 to 32,354 in the metropolitan stratum,
from 8 to 1,787 in the urban stratum, and from 10 to
1,358 in the rural stratum.) Because they were selected for
clinical evaluation only as a result of being matched to a
CFS-like subject, well subjects did not have their own clin-
ical-evaluation weight.
Prevalence estimates
Within each stratum, prevalence was estimated using
SUDAAN (SUDAAN: Research Triangle Institute, Research
Triangle Park, NC) [18] software to calculate weighted
percentages and obtain standard errors that reflected the
sample design and survey weights. Prevalence estimates
based on illness classifications derived from the detailed
interviews used the data of all subjects who completed
detailed interviews, and their respective interview weights.
In order to maintain the relation to the population, prev-
alence estimates based on illness classifications derived
from clinical data used a combination of clinical data and
interview data. For CFS-like and chronically unwell sub-
jects who completed clinical evaluations, the data
obtained from the clinical evaluations were used along
with their clinical-evaluation weights. For subjects classi-
fied as CFS-like and chronically unwell who were not eli-
gible for clinical evaluations, and also for all well subjects,
the data obtained from detailed interviews were used
along with their interview weights.
Because the matching process does not preserve a sam-
pling-based connection with the population, clinical data
from well subjects were not used in calculating prevalence
estimates.
Statistical analyses
Weighted χ2 tests in SUDAAN were used to compare pro-
portions of subjects diagnosed with CFS by demographic
categories. P-values were calculated to evaluate the statis-
tical significance of differences in CFS prevalence by age,
sex, race, ethnicity, education and household income.
Results
Screening telephone interview
Overall, 105,000 telephone numbers were selected for a
screening interview; 66,295 (63%) were ineligible
because they belonged to businesses, were not working, or
were cellular phones. Residential status could not be
determined for 24,594 (23%) of the numbers – 2,136
(2%) because all attempts produced no contact, 4,258
(4%) because attempts reached only an answering
machine, and 18,200 (17%) because of another outcome
(primarily the person refused to participate before house-
hold status could be determined). A total of 2,864 num-
bers (3%) belonged to households where all residents
were over the age of 59; these households were not eligi-
ble for the study. The remaining 11,247 numbers (11%)
were residential and eligible for screening. We completed
screening telephone interviews for 10,837 of the identi-
fied residential numbers (96% participation). Taking into
account estimated numbers of age-eligible households
among the telephone numbers for which residential sta-
tus could not be determined and among the households
for which screening was not completed, the response rate
for the screening step was 79%. There were no important
differences in response across the strata (range 76.1% to
81.4%).
The screening interviews enumerated 19,381 residents. Of
these, 10,834 (56%) were identified by the household
informant as well, 5,122 (26%) as unwell for at least a
month but not fatigued, and 3,425 (18%) as unwell and
fatigued for at least a month. We attempted to conductPopulation Health Metrics 2007, 5:5 http://www.pophealthmetrics.com/content/5/1/5
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detailed telephone interviews on all those who were
unwell with fatigue, and 2,438 (71%) completed the
detailed interview. We randomly selected 2,134 of those
who were unwell not fatigued, and 1,429 (67%) com-
pleted detailed interviews; similarly, 1,756 (56%) of
3,113 randomly selected household members identified
as well completed detailed telephone interviews. There
were no important differences in detailed interview com-
pletion across the strata (range 66.8% to 72.6%)
Telephone interview sample
Individuals' responses during the detailed telephone
interview roughly mirrored the household informants'
classification (Table 1). For example, 65% of those
described as well by household informants during the
screening interview, described themselves as 'well' during
the detailed interview. Similarly, 69% of those described
as unwell not fatigued by household informants,
described themselves as unwell not fatigued. A smaller
proportion (49%) of those who were initially described as
unwell fatigued by household informants described
themselves as unwell with fatigue during the detailed
interview. Following the detailed telephone interview
1,513 respondents were classified as well, 1,803 as unwell
for at least a month but not fatigued, 1,400 as unwell with
fatigue, and 907 as CFS-like, meaning that they fulfilled
all criteria of the 1994 case definition [11] on telephone
interview.
Responses during the detailed telephone interview identi-
fied a self-reported medical or psychiatric explanation for
the illness in 438 (48%) of CFS-like participants, 558
(40%) of those unwell with fatigue, and 429 (24%) of
those who were unwell but not fatigued. Interestingly,
184 (12%) of participants classified as well reported med-
ical and psychiatric conditions and these were in general
the same as those reported by participants with CFS-like
illness and those who were unwell.
Clinic sample
We invited all 469 individuals with CFS-like illness and
no medical/psychiatric exclusions for a clinical evalua-
tion, and 292 (62%) agreed to participate. Those who did
not come for a clinical evaluation were similar to those
who did with regard to age, sex, income, and duration of
illness. We randomly selected 505 from the 1,763 identi-
fied as chronically unwell (=> 6 months duration with or
without fatigue) and invited them to clinic; 268 (53%)
participated. Finally, we selected 641 interview partici-
pants classified as well (n = 481) or prolonged unwell, i.e.
unwell for 1 to 6 months duration (n = 160). These were
matched to the CFS-like on sex, race, and age (within 3
years). A total of 163 participants classified as well and 60
who were classified as prolonged unwell completed clini-
cal evaluations. As with telephone interviews, there were
no important differences in clinical evaluation participa-
tion across the three strata, either overall or by classifica-
tion status.
Clinical evaluation identified a medical or psychiatric
exclusion in 26 (16%) of those classified as well based on
their detailed telephone interview responses, 24 (40%) of
those with prolonged unwellness, 44 (30%) of the chroni-
cally unwell not fatigued, 45 (38%) of the chronically
unwell fatigued, and 141 (48%) of the CFS-like. The most
frequent medical exclusions included previously undiag-
nosed thyroid disease (24% of the total), anemia (18%),
uncontrolled diabetes (14%), autoimmune disease
(11%), inflammatory disease (8%), heart disease (7%),
arthritis (3%) and pulmonary disease (3%). Psychiatric
exclusions encompassed alcohol or substance abuse
(43%), melancholic depression (26%), bipolar disorder
(19%), psychosis (7%), and anorexia/bulimia (5%). One
subject enrolled with chronic unwellness and one CFS-
like subject had incomplete medical or psychiatric evalu-
ations and could not be classified.
Table 2 summarizes the relation between classification
following detailed telephone interview and clinic classifi-
cation among the 501 study subjects who did not have an
exclusionary condition. One hundred-thirteen met crite-
ria for CFS, 264 had an unexplained illness (ISF), and 124
were well. Interestingly, 53 (39%) of those who were clas-
sified as well based on their telephone interview data were
classified as ISF (insufficient symptoms or fatigue for CFS)
or CFS when evaluated in clinic, while 26 (15%) of those
enrolled as chronically unwell based on telephone inter-
view had no evidence of unwellness when evaluated in
clinic.
Prevalence estimates
Table 3 summarizes prevalence of CFS in metropolitan,
urban and rural populations according to demographic
characteristics. Overall, 2.54% of the study populations
had CFS; 83% reported gradual onset and 17% reported
sudden onset of their illness. There were no statistically
significant differences in prevalence of CFS among metro-
Table 1: Screening Interview Classification
Detailed Interview Well Unwell not 
Fatigued
Unwell 
Fatigued
Classification n = 1,756 n = 1,429 n = 2,438
Well (n = 1,513) 1,141 (65%) 242 (17%) 130 (5%)
Unwell not Fatigued 
(n = 1,803)
545 (31%) 982 (69%) 276 (11%)
Unwell Fatigued 
(n = 1,400)
57 (3%) 149 (10%) 1,194 (49%)
CFS-like (n = 907) 13 (1%) 56 (4%) 838 (34%)
(%) indicates column percentPopulation Health Metrics 2007, 5:5 http://www.pophealthmetrics.com/content/5/1/5
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politan, urban, and rural populations among women (p =
.37). However, among men, CFS prevalence varied signif-
icantly among geographic strata, and was lowest in the
metropolitan stratum (p = .038). In the metropolitan
area, the CFS prevalence in women was 11.2 times that in
men (p = .009), whereas in the urban and rural popula-
tions the female-to-male ratios of CFS prevalence were 1.7
and 0.8, respectively, and did not represent statistically
significant differences.
Overall, white and black adults had roughly similar rates
(2.3% and 2.9%, respectively). Although Hispanic adults
in metropolitan and rural populations had considerably
higher prevalence than non-Hispanic, the numbers of
Hispanics interviewed were low (23 in the metropolitan
area, 38 urban, and 59 rural), and the differences were not
statistically significant.
Age-specific prevalence of CFS differed among age catego-
ries in urban and rural populations (p = .041 and p =
.0001, respectively), but not in metropolitan (p = .224).
The rate was lowest among urban and rural adults aged
18–29 and highest among rural adults aged 50–59.
The prevalence of CFS was not significantly related to level
of education in metropolitan, urban or rural strata (p =
.129, p = .486, and p = .695, respectively). Similarly, CFS
prevalence was not significantly related to household
income in these strata (p = .741, p = .900, and p = .373,
respectively).
Discussion
This is the first published study, of which we are aware,
that screened defined populations for unwellness and
then used standardized, validated instruments to define
CFS, unwellness, and wellness based on functional
impairment, characteristics of fatigue, and frequency/
severity of the 8 case defining symptoms [7]. Using this
approach, we found 2.54% of the Georgia population to
suffer from CFS, which was 10-fold higher than previous
estimates in the population of Wichita (0.24%) [3] and 6-
fold higher than estimated in the Chicago population
(0.42%) [5]. We are aware of no other published popula-
tion-based surveys of CFS. However, several studies have
published estimates of CFS prevalence; although they can-
not be directly compared to the 2 U.S. studies, their prev-
alence estimates serve to put the present study into a more
complete perspective. A well-conducted survey of the
Group Health Cooperative of Puget Sound estimated that
between 0.75 and 0.27% of that HMO population had
CFS [19]. A survey of primary care patients in England,
published in 1997, estimated that 2.6% of that popula-
tion met criteria for CFS [20]. Finally, analysis of data
from the Australian National survey of Mental Health and
Wellbeing estimated that 1.5% of the Australian adult
population suffers from chronic neurasthenia (defined
similarly to CFS) [21].
In part, the increased prevalence we estimated in Georgia
reflects a difference in screening criteria. The Georgia sur-
vey screened for unwell  (the core symptoms of CFS),
whereas previous studies have screened only for fatigue.
Our less restrictive approach allowed the inclusion of
potential cases whom, although noted as unwell-not
Table 3: Prevalence of CFS (in percent) by Demographic 
Characteristics in the Three Populations
Metropolitan Urban Rural
% (SE) % (SE) % (SE)
Overall prevalence 2.55 (0.85) 2.48 (0.67) 2.66 (0.58)
Sex
Female 4.70 (1.60) 3.10 (0.81) 2.40 (0.57)
Male 0.42 (0.37) 1.82 (1.08) 2.89 (0.97)
Race
White 3.72 (1.71) 2.39 (0.70) 3.20 (0.72)
Black 1.78 (0.63) 2.71 (1.27) 1.71 (1.00)
Ethnicity
Hispanic 21.21 (11.97) 7.02 (6.74) 0.70 (0.71)
Non-Hispanic 2.25 (0.82) 2.30 (0.64) 2.72 (0.59)
Age
18–29 4.15 (2.28) 0.54 (0.29) 0.00
30–39 0.74 (0.43) 5.59 (2.40) 2.68 (1.06)
40–49 2.64 (1.34) 2.38 (0.83) 2.08 (0.77)
50–59 2.11 (1.13) 1.74 (1.09) 6.88 (2.17)
Education
=< High School 
Graduation
0.00 1.02 (0.73) 2.48 (1.10)
High School Graduate 1.60 (1.24) 2.54 (1.02) 3.80 (1.34)
Technical or Some 
College
2.02 (1.01) 3.05 (1.60) 2.33 (1.15)
=> College Graduate 3.44 (1.47) 2.60 (1.25) 1.97 (0.72)
Household Income
=< $20,000 4.85 (4.01) 1.87 (1.06) 1.87 (0.83)
$20,001–$40,000 3.43 (2.49) 2.89 (1.57) 4.72 (1.70)
>$41,000 1.60 (0.61) 2.79 (1.19) 2.25 (0.80)
Poverty Level
=< $20,000 4.85 (4.01) 1.87 (1.06) 1.87 (0.83)
> $20,001 2.09 (0.80) 2.82 (0.95) 3.09 (0.79)
Table 2: Clinic Classification of Participants with No Exclusionary 
Conditions
Clinic Classification
Detailed Interview Well ISF CFS
Classification (n = 124) (n = 264) (n = 113)
Well (n = 137) 83 (61%) 53 (39%) 1 (1%)
Prolonged Unwell (n = 36) 15 (42%) 19 (53%) 2 (6%)
Unwell not Fatigued (n = 104) 20 (19%) 74 (71%) 10 (10%)
Unwell Fatigued (n = 74) 6 (8%) 52 (70%) 16 (22%)
CFS-like (n = 150) 0 (0%) 66 (44%) 84 (56%)
(%) indicates row percentPopulation Health Metrics 2007, 5:5 http://www.pophealthmetrics.com/content/5/1/5
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fatigued by a household informant, endorsed chronic
fatigue upon detailed in-person interviewing. Sixty-nine
people whom the household informant identified during
the screening telephone interview as well or unwell with-
out fatigue were classified as CFS-like based on their
responses during detailed telephone interview (7.6% of
all CFS-like). Further, 13 clinic participants classified as
well or unwell without fatigue, based on their detailed tel-
ephone interview were diagnosed as CFS when evaluated
clinically. In other words, 11.5% of subjects with CFS
would not have been detected in previous studies that
queried participants only for fatigue.
The 6- to 10-fold greater prevalence estimates also reflect
application of more sensitive and specific measures of the
CFS diagnostic parameters specified by the 1994 case def-
inition. Previous prevalence estimates from population
surveys and those based on patients attending clinics did
not use validated standardized instruments to define CFS;
rather they simply queried as to the presence or absence of
fatigue, accompanying symptoms, and impairment. In
2003, the International Chronic Fatigue Syndrome Study
Group published recommendations concerning applica-
tion of the case definition [7]. They recommended the use
of validated instruments to obtain standardized measures
of the major symptom domains of the illness, and this
study implemented those recommendations. The Study
Group specifically recommended: 1) the SF-36, to measure
functional impairment; 2) the Checklist Individual
Strength or MFI, to obtain reproducible quantifiable
measures of fatigue; 3) and the CDC Symptom Inventory
to document toe occurrence, duration and severity of the
symptom complex. The manner in which we applied the
case definition in Georgia has been shown to detect about
3 times the number of CFS cases as verbatim application
of the 1994 definition [8]. Of course, we cannot exclude
the possibility that CFS prevalence may be higher in Geor-
gia than Wichita and Chicago.
However, the manner in which we chose and applied sub-
scales and their cutoffs from the SF-36 and MFI can be
debated. We used the SF-36 physical function, role physi-
cal, social function and role emotional subscales to define
an illness severe enough to "result in substantial reduction
in previous levels of occupational, educational, social, or
personal activities." [11]. In particular, we included the
role emotional subscale to capture the relation between
functional emotional impairment and reduced social and
personal activities. We ascertained the onset and duration
of fatigue during interview (the case definition requires =>
6 months of fatigue that is of new or definite onset) and
utilized the MFI general fatigue and reduced activity scales
to define severe fatigue. We used stringent (i.e., =< 25th
percentile population norms on any of the 4 SF-36 scales)
to define severe functional impairment. Numerous publi-
cations tabulate slightly different population norms and
we chose those published by Quality Metric [22]. We are
not aware of published population norms for the MFI, so
we used the cut-offs established in a previous CDC study
(=> than the median determined in Wichita) [8], which is
more sensitive and less specific than the 25th percentile SF-
36 cutoff. There are no population norms for the Symp-
tom Inventory, so we also used cutoffs applied in the pre-
vious study. Finally, population norms are not cast in iron
and one might consider defining cut-offs specific to each
population studied. In the end, we decided to use these
cutoffs because we believe they make sense; because we
used them in the Wichita study and can compare findings
in similarly ill individuals; and, because others can repli-
cate the findings if they use the same cutoffs and stratify
their populations based on variations of the cutoffs.
The other important new finding is that, despite differ-
ences in demographic factors, CFS prevalence was similar
in the metropolitan, urban, and rural populations we sur-
veyed (about 2.5%). However, differences in sex-specific
prevalence among the strata must be evaluated in more
detail. The striking differences between female and male
rates in the 3 strata may indicate risk effects of gender (a
social construct) in distinction to sex (a biologic
attribute). In addition, the high prevalence among those
of Hispanic ethnicity in the metropolitan area bears fur-
ther investigation in a study designed to include Spanish-
speaking persons.
The final major finding concerns the high proportion of
study participants in whom the survey documented previ-
ously undiagnosed medical or psychiatric conditions.
Overall 48% of persons recruited for clinical evaluation
because CFS-like illness was identified on phone inter-
view had exclusionary medical or psychiatric conditions,
which is similar to the occurrence of such illness in other
studies [2,3]. Most of these exclusions are amenable to
treatment if appropriately recognized. It is also important
to note the relatively common occurrence of such condi-
tions in people with other categories of unwellness iden-
tified during the phone interview. Indeed, 16% of
respondents classified as well on the basis of interview
had such exclusions identified. Further analyses will
address whether the onset of psychiatric illness preceded
or followed development of CFS-like illness.
Interpretation of the findings must consider obvious
study weaknesses. First, like other telephone surveys, we
faced challenges of nonresponse. Potential respondents
can be lost in the processes of determining whether tele-
phone numbers belong to households, completing
screening interviews with household respondents, and
maintaining contact with selected subjects to complete
detailed interviews. In addition, some people are reluctantPopulation Health Metrics 2007, 5:5 http://www.pophealthmetrics.com/content/5/1/5
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to schedule a full-day clinical examination. A random-
digit-dialing survey that subsamples some types of sub-
jects does not have a standard, single-number response
rate. Taking into account the resolution of sampled tele-
phone numbers (as residential or not), completion of
screening interviews, and completion of detailed inter-
views, we calculated a response rate of 47.8% through the
detailed interview. A further calculation, including the
completion of clinical evaluations by subjects with CFS-
like illness and chronically unwell subjects, produced a
response rate of 27.5% through the clinic stage. Although
nonresponse is always an appropriate subject for concern,
detailed adjustments in the sampling weights often are
able to mitigate its adverse effects. Thus, the adjustment
for nonresponse on the detailed interview used a total of
195 cells, taking into account stratum, illness classifica-
tion, sex, age, and race; post-stratification aligned
respondents' weights with population totals; and the
adjustment for nonresponse on the clinical evaluation
used a total of 33 cells based on stratum, illness classifica-
tion, sex, and age.
The second weakness concerns obtaining clinical infor-
mation by telephone interview. Initial classification of
subjects as well, unwell not fatigued, and unwell fatigued
based on telephone interviews with household inform-
ants was confirmed by detailed interviews in 65%, 69%
and 49% of subjects in those respective categories. Except
for the unwell fatigued group, these levels of agreement
between household informants and self-reports were sim-
ilar to the 66% agreement detected in a study designed to
examine concordance between self-reported health condi-
tions and proxy information among adults => 65 years of
age in the United Kingdom [23]. This degree of agreement
was considered reasonable. The lower level of agreement
detected among the unwell fatigued may be due to the rel-
ative nonspecificity of fatigue, compared to other symp-
toms of unwellness, including problems with memory/
concentration, unrefreshing sleep, or muscle/joint pain.
Third, the study was conducted in standard 8th grade-level
English, which may have led to an under-sampling of eth-
nic minority groups (e.g., Spanish speaking). Prevalence
of CFS was unusually high among the metropolitan and
rural Hispanic populations and unusually low among
rural Hispanic residents. This may reflect important ethnic
differences in risk [2] and we weighted the sample to
allow for ethnic differences. Most likely it reflects lan-
guage-related misunderstanding of the questions and
weighting cannot address this. It will be important to fur-
ther evaluate the occurrence of and risk factors for CFS in
English and non-English speaking metropolitan, urban,
and rural Hispanic populations [24].
Fourth, the study utilized Atlanta (Fulton and DeKalb
counties) to represent metropolitan Georgia, Macon and
Warner Robins to represent urban Georgia, and the coun-
ties surrounding the urban area to represent rural Georgia.
We did this for logistic reasons, and the results cannot a-
priori be generalized to other populations. Indeed, popu-
lations of the 10 rural county seats varied from 587 to
19,000 (median 2,000), so several exceeded the Census
Bureau definition of rural.
Finally, in spite of a rigorous case definition, CFS has no
diagnostic markers or characteristic physical signs. Thus,
CFS diagnosis is based on self-reported symptoms, disa-
bility and exclusion of known diseases. Therefore, poten-
tial misclassification of study subjects remains a concern,
as CFS is clinically heterogeneous and likely represents
more than one entity [25,26].
Conclusion
In conclusion, this investigation suggests that 2.54% of
the adult population of Georgia suffers from CFS. This fig-
ure is 6- to 10-fold higher than previous prevalence esti-
mates and likely reflects improved screening methods and
more sensitive and specific diagnostic criteria. However,
this is the first study to measure CFS prevalence in Geor-
gia, so we cannot rule out the possibility that CFS preva-
lence is higher in Georgia than other geographic areas
where CFS prevalence has been reported. We did not find
evidence for metropolitan, urban, rural differences in the
prevalence of CFS, nor did we find differences in preva-
lence between white and black populations. These find-
ings are important for public health officials, health care
providers, and the public in general. The methodology
and findings from this study should be of interest to those
studying CFS and those with responsibilities for health
care in other states in the US and in other countries.
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